Eolo Pharma
Phase 1SANA’s novel mechanism targets energy balance through thermogenesis, offering a new pathway for effective, sustainable weight management. Designed to address unmet needs for patients who may not benefit from or tolerate current therapies
Founded
2019
Focus
Small Molecules
About
SANA’s novel mechanism targets energy balance through thermogenesis, offering a new pathway for effective, sustainable weight management. Designed to address unmet needs for patients who may not benefit from or tolerate current therapies
Company Info
TypePrivate
Founded2019
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile